Phase II Trial of AZD2014 in TSC1/2 Mutated or TSC1/2 Null GC Patients as Second-line Chemotherapy

NCT03082833 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped lack of efficacy

Conditions

Cancer of Stomach

Interventions

DRUG: AZD2014

Sponsor

Samsung Medical Center